MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
7.67
+0.24
+3.16%
Opening 15:28 02/09 EST
OPEN
7.42
PREV CLOSE
7.43
HIGH
7.70
LOW
7.22
VOLUME
199.12K
TURNOVER
--
52 WEEK HIGH
9.73
52 WEEK LOW
4.550
MARKET CAP
616.96M
P/E (TTM)
-3.6344
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MGTX last week (0202-0206)?
Weekly Report · 11h ago
MeiraGTx and ZipBio sign exclusive license agreement for geographic atrophy
TipRanks · 6d ago
MeiraGTx Signs Exclusive License Agreement With ZipBio for Geographic Atrophy Gene Therapy
Reuters · 6d ago
MeiraGTx Holdings plc schließt exklusive Lizenzvereinbarung mit ZipBio für Gentherapie bei geografischer Atrophie
Reuters · 6d ago
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
PR Newswire · 6d ago
Weekly Report: what happened at MGTX last week (0126-0130)?
Weekly Report · 02/02 09:14
Weekly Report: what happened at MGTX last week (0119-0123)?
Weekly Report · 01/26 09:14
Weekly Report: what happened at MGTX last week (0112-0116)?
Weekly Report · 01/19 09:15
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.